A citation-based method for searching scientific literature

Fabio Arturo Iannotti, Charlotte L Hill, Antonio Leo, Ahlam Alhusaini, Camille Soubrane, Enrico Mazzarella, Emilio Russo, Benjamin J Whalley, Vincenzo Di Marzo, Gary J Stephens. ACS Chem Neurosci 2014
Times Cited: 228







List of co-cited articles
1253 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott, Vincenzo Di Marzo. Br J Pharmacol 2011
525
31

Agonistic properties of cannabidiol at 5-HT1a receptors.
Ethan B Russo, Andrea Burnett, Brian Hall, Keith K Parker. Neurochem Res 2005
503
29

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
540
27

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Orrin Devinsky, J Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E Scheffer, Elizabeth A Thiele, Stephen Wright. N Engl J Med 2017
743
25

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
T Bisogno, L Hanus, L De Petrocellis, S Tchilibon, D E Ponde, I Brandi, A S Moriello, J B Davis, R Mechoulam, V Di Marzo. Br J Pharmacol 2001
749
24

The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
23

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt,[...]. Epilepsia 2014
508
23

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Joshua S Kaplan, Nephi Stella, William A Catterall, Ruth E Westenbroek. Proc Natl Acad Sci U S A 2017
202
21

Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
T D M Hill, M-G Cascio, B Romano, M Duncan, R G Pertwee, C M Williams, B J Whalley, A J Hill. Br J Pharmacol 2013
127
21

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham,[...]. N Engl J Med 2018
428
18


Cannabidivarin is anticonvulsant in mouse and rat.
A J Hill, M S Mercier, T D M Hill, S E Glyn, N A Jones, Y Yamasaki, T Futamura, M Duncan, C G Stott, G J Stephens,[...]. Br J Pharmacol 2012
107
18

Molecular Targets of the Phytocannabinoids: A Complex Picture.
Paula Morales, Dow P Hurst, Patricia H Reggio. Prog Chem Org Nat Prod 2017
218
16

Cannabinoid Ligands Targeting TRP Channels.
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
241
15

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwee. Br J Pharmacol 2015
308
15

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Erica J Carrier, John A Auchampach, Cecilia J Hillard. Proc Natl Acad Sci U S A 2006
306
14


Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Markus Kathmann, Karsten Flau, Agnes Redmer, Christian Tränkle, Eberhard Schlicker. Naunyn Schmiedebergs Arch Pharmacol 2006
212
13

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Danilo De Gregorio, Ryan J McLaughlin, Luca Posa, Rafael Ochoa-Sanchez, Justine Enns, Martha Lopez-Canul, Matthew Aboud, Sabatino Maione, Stefano Comai, Gabriella Gobbi. Pain 2019
148
13

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Elizabeth A Thiele, Eric D Marsh, Jacqueline A French, Maria Mazurkiewicz-Beldzinska, Selim R Benbadis, Charuta Joshi, Paul D Lyons, Adam Taylor, Claire Roberts, Kenneth Sommerville. Lancet 2018
424
13

Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Nicholas A Jones, Andrew J Hill, Imogen Smith, Sarah A Bevan, Claire M Williams, Benjamin J Whalley, Gary J Stephens. J Pharmacol Exp Ther 2010
215
13

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors.
T Bakas, P S van Nieuwenhuijzen, S O Devenish, I S McGregor, J C Arnold, M Chebib. Pharmacol Res 2017
108
13

Molecular Targets of Cannabidiol in Neurological Disorders.
Clementino Ibeas Bih, Tong Chen, Alistair V W Nunn, Michaël Bazelot, Mark Dallas, Benjamin J Whalley. Neurotherapeutics 2015
293
12

Preclinical safety and efficacy of cannabidivarin for early life seizures.
Megan N Huizenga, Alberto Sepulveda-Rodriguez, Patrick A Forcelli. Neuropharmacology 2019
28
42

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
Orrin Devinsky, Anup D Patel, Elizabeth A Thiele, Matthew H Wong, Richard Appleton, Cynthia L Harden, Sam Greenwood, Gilmour Morrison, Kenneth Sommerville. Neurology 2018
224
12


Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Orrin Devinsky, Eric Marsh, Daniel Friedman, Elizabeth Thiele, Linda Laux, Joseph Sullivan, Ian Miller, Robert Flamini, Angus Wilfong, Francis Filloux,[...]. Lancet Neurol 2016
512
11

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Br J Pharmacol 2007
469
11

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Barbara Costa, Gabriella Giagnoni, Chiara Franke, Anna Elisa Trovato, Mariapia Colleoni. Br J Pharmacol 2004
168
11

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
L De Petrocellis, P Orlando, A Schiano Moriello, G Aviello, C Stott, A A Izzo, V Di Marzo. Acta Physiol (Oxf) 2012
179
11

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
Luciano De Petrocellis, Vittorio Vellani, Aniello Schiano-Moriello, Pietro Marini, Pier Cosimo Magherini, Pierangelo Orlando, Vincenzo Di Marzo. J Pharmacol Exp Ther 2008
226
11

TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.
Ning Qin, Michael P Neeper, Yi Liu, Tasha L Hutchinson, Mary Lou Lubin, Christopher M Flores. J Neurosci 2008
255
11

Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.
Naoki Amada, Yuki Yamasaki, Claire M Williams, Benjamin J Whalley. PeerJ 2013
52
21

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
Alexandra L Geffrey, Sarah F Pollack, Patricia L Bruno, Elizabeth A Thiele. Epilepsia 2015
296
10

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Mylyne Tham, Orhan Yilmaz, Mariam Alaverdashvili, Melanie E M Kelly, Eileen M Denovan-Wright, Robert B Laprairie. Br J Pharmacol 2019
143
10

The capsaicin receptor: a heat-activated ion channel in the pain pathway.
M J Caterina, M A Schumacher, M Tominaga, T A Rosen, J D Levine, D Julius. Nature 1997
10

Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.
Sabatino Maione, Fabiana Piscitelli, Luisa Gatta, Daniela Vita, Luciano De Petrocellis, Enza Palazzo, Vito de Novellis, Vincenzo Di Marzo. Br J Pharmacol 2011
95
10

Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
10

Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
Luciano R Vilela, Isabel V Lima, Érica B Kunsch, Hyorrana Priscila P Pinto, Aline S de Miranda, Érica Leandro M Vieira, Antônio Carlos P de Oliveira, Marcio Flávio D Moraes, Antônio L Teixeira, Fabricio A Moreira. Epilepsy Behav 2017
59
16

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.
Giuseppe Esposito, Caterina Scuderi, Marta Valenza, Giuseppina Ines Togna, Valentina Latina, Daniele De Filippis, Mariateresa Cipriano, Maria Rosaria Carratù, Teresa Iuvone, Luca Steardo. PLoS One 2011
233
10

An update on PPAR activation by cannabinoids.
Saoirse Elizabeth O'Sullivan. Br J Pharmacol 2016
239
10




GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
Jane E Lauckner, Jill B Jensen, Huei-Ying Chen, Hui-Chen Lu, Bertil Hille, Ken Mackie. Proc Natl Acad Sci U S A 2008
469
9

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
9


Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.
T V Zanelati, C Biojone, F A Moreira, F S Guimarães, Sâmia R L Joca. Br J Pharmacol 2010
238
9

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.
E M Rock, D Bolognini, C L Limebeer, M G Cascio, S Anavi-Goffer, P J Fletcher, R Mechoulam, R G Pertwee, L A Parker. Br J Pharmacol 2012
152
9

Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.
Andrew J Hill, Samantha E Weston, Nicholas A Jones, Imogen Smith, Sarah A Bevan, Elizabeth M Williamson, Gary J Stephens, Claire M Williams, Benjamin J Whalley. Epilepsia 2010
72
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.